MedPath

Treatment of acne vulgaris

Not Applicable
Conditions
Acne vulgaris.
Acne vulgaris
Registration Number
IRCT2013040812758N2
Lead Sponsor
Iraqi Board for Medical Specializations
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
36
Inclusion Criteria

All patients with mild to moderate acne vulgaris will enrolled in the study. All patients must without any systemic and / or topical treatment for at least 2 months before starting the study.
Exclusion criteria: Patients excluded from the study were those with severe acne, nodulocystic acne, patients with systemic diseases, pregnant and lactating women.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Change in acne scoring.(mild,moderate,severe)Mild acne in which the count of pustules is less than 20 and the count of papules is less than 10. Timepoint: Each patient was instructed to use the same amount of both gels (finger tip method), ½ hour in the 1st night then wash and increase the time by ½ hour in the successive nights till reach 8 hours; thereafter to keep the applications till morning. The duration of therapy was 6 weeks and follow up for another 6weeks. Method of measurement: The clinical evaluation was done every 3 weeks by 2 dermatologists; the assessment was carried out by counting the inflammatory lesions (papules and pustules) and watching any local side effects.
Secondary Outcome Measures
NameTimeMethod
The satisfaction of the patient with the treatment. Timepoint: The clinical evaluation was done every 3 weeks. Method of measurement: The satisfaction of the patients to the treatment is classified into:1- Full satisfaction.2- Partial satisfaction.3 - No satisfaction.
© Copyright 2025. All Rights Reserved by MedPath